The DOJ withdrew three policy statements on healthcare antitrust enforcement, saying they are ‘overly permissive on certain subjects, such as information sharing,’ and that ‘a case-by-case enforcement approach’ would allow it to better evaluate healthcare mergers and competition.
The policies include a 1993 statement describing circumstances under which DOJ and the Federal Trade Commission would not challenge certain hospital mergers and health care joint ventures; a 1996 statement on health care provider networks; and a 2011 statement regarding accountable care organizations participating in the Medicare Shared Savings Program.
Related: US DOJ Seeks More Info On $8B CVS-Signify Health Deal
“AHA is deeply disappointed with the precipitous withdrawal of guidelines for hospitals and other health care providers and with DOJ’s unsupported assertion that some were ‘overly permissive,’” said AHA General Counsel Melinda Hatton. “Over the years, AHA has urged both federal antitrust agencies to modernize the guidelines to accommodate the need for more flexibility in enforcement actions to support hospitals’ ability to navigate a changing health care landscape. And, AHA was instrumental in securing appropriate ACO guidance that allowed hospitals to fully participate in that important program. Withdrawing all the guidance without consultation with the field is both unnecessary and reckless.”
The FTC is expected to follow DOJ’s lead in the coming weeks.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI